Albinism

13 registered clinical trials studyying Albinism — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Implementation of Long-read Sequencing for the Diagnosis of Rare Diseases. NCT07400913	University Hospital, Bordeaux	—
Recruiting	National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion o NCT06491615	National Eye Institute (NEI)	—
Enrolling By Invitation	Reproductive Options in Inherited Skin Diseases NCT06330324	Maastricht University Medical Center	—
Recruiting	Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling NCT06330350	Maastricht University Medical Center	—
Unknown	Functional Tests to Resolve Unsolved Rare Diseases. Rares. NCT05696912	University Hospital, Bordeaux	N/A
Completed	Genetic Analysis and Multimodal Retinal Imaging of Asymptomatic Fovea Plana Cases in the General Population NCT04658381	Fondation Ophtalmologique Adolphe de Rothschild	N/A
Unknown	Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those Wi NCT04281732	Queen's University, Belfast	—
Recruiting	FARD (RaDiCo Cohort) (RaDiCo-FARD) NCT05954416	Institut National de la Santé Et de la Recherche Médicale, France	—
Completed	Nitisinone for Type 1B Oculocutaneous Albinism NCT01838655	National Eye Institute (NEI)	Phase 1 / Phase 2
Terminated	Vision Response to Dopamine Replacement NCT01663935	University of Wisconsin, Madison	Phase 2
Completed	Trial of L-DOPA as a Treatment to Improve Vision in Albinism NCT01176435	University of Minnesota	Phase 2
Completed	Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome NCT00001596	William Gahl, M.D.	Phase 2
Completed	Visual Function and Ocular Pigmentation in Albinism NCT00001153	National Eye Institute (NEI)	—